Page last updated: 2024-11-04

1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Cancer of Lung

1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with Cancer of Lung in 2 studies

1,4-bis(2-(3,5-dichloropyridyloxy))benzene: potent phenobarbital-like inducer of microsomal monooxygenase activity; structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukumasu, H1
Rochetti, AL1
Pires, PR1
Silva, ER1
Mesquita, LG1
Strefezzi, RF1
De Carvalho, DD1
Dagli, ML1
Diwan, BA1
Lubet, RA1
Ward, JM1
Hrabie, JA1
Rice, JM1

Other Studies

2 other studies available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Cancer of Lung

ArticleYear
Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.
    PloS one, 2014, Volume: 9, Issue:6

    Topics: Androstenols; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cons

2014
Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with
    Carcinogenesis, 1992, Volume: 13, Issue:10

    Topics: Animals; Carcinogens; Carcinoma, Hepatocellular; Dimethylnitrosamine; Drug Synergism; Liver Neoplasm

1992